Prediction of response to systemic treatment by kinetics of circulating tumor DNA in metastatic pancreatic cancer

INTRODUCTION: Pretherapeutic detectable circulating tumor DNA (ctDNA) represents a promising prognostic biomarker for predicting relapse and overall survival in patients with metastatic pancreatic cancer. However, the prognostic value of ctDNA dynamics during treatment has not been studied thus far....

Descripción completa

Detalles Bibliográficos
Autores principales: Kirchweger, Patrick, Kupferthaler, Alexander, Burghofer, Jonathan, Webersinke, Gerald, Jukic, Emina, Schwendinger, Simon, Wundsam, Helwig, Biebl, Matthias, Petzer, Andreas, Rumpold, Holger
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468369/
https://www.ncbi.nlm.nih.gov/pubmed/36110940
http://dx.doi.org/10.3389/fonc.2022.902177

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468369/
https://www.ncbi.nlm.nih.gov/pubmed/36110940
http://dx.doi.org/10.3389/fonc.2022.902177

Ejemplares similares